Cadrenal Therapeutics, Inc. (CVKD) (CIK 0001937993) (CVKD)
Activity window: Oct. 25, 2025 to Oct. 24, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Apr. 27, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 27, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Cadrenal Therapeutics, Inc. that it will not review their registration statement filed on April 21, 2026. The letter emphasizes that the responsibility… | Read Filing EDGAR |
| Apr. 27, 2026 | CORRESP | Neutral/Informational | Moderate | Cadrenal Therapeutics, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-3. They are seeking to have it become eff… | Read Filing EDGAR |
| Dec. 31, 2025 | UPLOAD | Neutral/Informational | Low | The SEC correspondence informs Cadrenal Therapeutics, Inc. that their registration statement on Form S-1, filed on December 29, 2025, will not be reviewed. The SEC emphasizes that… | Read Filing EDGAR |
| Dec. 30, 2025 | CORRESP | Neutral/Informational | Moderate | Cadrenal Therapeutics, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1 to December 31, 2025. The company ackno… | Read Filing EDGAR |